Hydroxyurea

CAS 127-07-1 8 FDA-DMF suppliersSmall Molecule

Overview

Hydroxyurea is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL467).

API suppliers (12)

Suppliers of Hydroxyurea backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • OLON SPAItaly2 active DMF
  • ARCHIMICA SPA1 active DMF
  • ARCHIMICA SPA1 active DMF
  • SHANDONG XINHUA PHARMACEUTICAL CO LTDChina1 active DMF
  • SHANDONG XINHUA PHARMACEUTICAL CO LTDChina1 active DMF
  • ARCHIMICA SPA1 active DMF
  • SHANDONG XINHUA PHARMACEUTICAL CO LTDChina1 active DMF
  • MEDEA RESEARCH LABORATORIES INC
  • DSM PHARMA CHEMICALS SOUTH HAVEN INC
  • CHEMSPEC
  • BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE
  • SQUIBB

Patent & exclusivity (US)

Per the FDA Orange Book (8 approved US products), the latest listed US patent on Hydroxyurea expires 23 Dec 2041 and exclusivity 3 Apr 2031. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name
hydroxyurea
Canonical SMILES
C(=O)(N)NO
InChIKey
VSNHCAURESNICA-UHFFFAOYSA-N

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo